Japan-based pharma firm Daiichi Sankyo and global life sciences company Merck, known as MSD outside of the United States...
Japan-based Terumo Corporation has established Terumo Ventures, a Corporate Venture Capital (CVC) organisation responsib...
Japan-based Otsuka Pharmaceutical Co. and Jnana Therapeutics Inc. have entered into a definitive merger agreement ...
Kyowa Kirin Asia Pacific, a wholly owned subsidiary of Japan-based Kyowa Kirin Co., has announced plans to transform its...
Biogen Inc., Beckman Coulter, Inc. (both based in the US) and Japan-based Fujirebio have announced a collaboration to po...
AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Gene Th...
Japanese firms Eisai Co. and EcoNaviSta Inc. have entered into a business alliance agreement and commenced collaboration...
Japan-headquartered Fujifilm Corporation has announced the opening of a new NURA health screening centre focusing on...
Japan-headquartered pharma firm Eisai Co. has entered into a license agreement regarding the development and commerciali...
Japan-headquartered Astellas Pharma Inc. and Graduate School of Medicine / Faculty of Medicine, Osaka University ha...
Nipro Medical Corporation, a subsidiary of Japan headquartered Nipro Corporation, has announced its significant expansio...
Acute graft-versus-host disease (aGVHD) is a medical condition that occurs when donor immune cells attack the recipient'...
Shimadzu Corporation has concluded a business partnership agreement with Tescan Group, a leading manufacturer of scannin...
Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation have entered into a joint agreement regarding the co-promot...
TMS Co. has entered into an exclusive worldwide license agreement with Hokkaido University concerning a therapeuti...
The School of Engineering, the University of Tokyo, Shimadzu Corporation and Shionogi & Co. have established the Lab...
Japan-based pharmaceutical firm Eisai Co. has agreed to end its global strategic collaboration with Bristol Myers Squibb...
